Science Capital Event: Drugs, Diagnostics and Delivery

Innovative Healthcare Meeting

The Innovative Healthcare Meeting entitled “Drugs, Diagnostics and Delivery: from Personalised Medicine to Global Health” will take place on the evening of Wednesday 15th September 2010 at the Birmingham Conservatoire.  Talks include:

“Cancer Treatment, Diagnosis and Clinical Trials”  by Professor Philip Johnson, Director of the Cancer Research UK Clinical Trials Unit, University of Birmingham, which runs up to forty trials at any one time, encompassing all stages of drug development from 'first use' studies to large randomized trials involving up to ten thousand patients.

 

“Biomarkers: from R&D to clinical studies”  by Dr Subhasis Banarjee, Director of Origin Biomarkers and based at Heartlands Hospital, which won support from Advantage West Midlands to commercialise new immunodiagnostic assays for pregnancy disorders, and is developing biological markers for cancer and inflammatory disorders.

 

“Meeting clinical needs through innovative technologies”  by Professor Monica Spiteri, Director of Lung Research at the University Hospital of North Staffordshire and Keele University; her group is developing near patient technologies for Chronic Obstructive Airways Disease with support from the National Institute of Health Research and NHS West Midlands Innovations.

Experts from across the West Midlands are joining in to explore opportunities to work together. Plans for individual innovators and SMEs to succeed in the sector will be formulated over food and drinks. 

Meetings with business leaders and investors will be arranged, and scientists are invited to submit business plan summaries.  The panel of investors and financial advisors includes Robert Heed (Beer & Partners), Everard Mascarenhas (Mercia Fund) and Brian Miller (FD Solutions).

Details and tickets are available at www.sciencecapital.co.uk/biomedical.  The meeting costs £50 (business) or £35 (academic) to attend; delegates should register in advance.  Tickets include the reception, dinner, all the talks and discussions, networking session and the opportunity to present posters and arrange follow-up meetings.

This event is part of the British Science Festival.  Supported by Anthony Collins Solicitors, Binding Site, Birmingham City Council, Birmingham Science City, FD Solutions, Lunar Society, MedilinkWM, Netnak, Royal Society of Medicine and UnLtd.  The charity of the evening is Cure Leukaemia.

Further information:
Prof Michael Overduin
Director, Science Capital
michael@sciencecapital.co.uk
Tel: 07810 444 960

Science Capital is an inclusive and independent organization.  We bring together scientists and business experts, innovators and investors. Join for free at www.sciencecapital.co.uk.